Obatoclax overcomes resistance to cell death in aggressive thyroid carcinomas by countering Bcl2a1 and Mcl1 overexpression.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Samuel Refetoff Antonio Di Cristofano |
| Publication date | July 10, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |